ACTRN12606000359538尚未招募3 期
A randomized placebo controlled double blind pilot trial of unregistered drug MKTVIF75HV on brain magnetic resonance imaging indices in multiple sclerosis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Relapsing remitting multiple sclerosis, gadolinium enhancing lesion(s) on screening brain MRI scan with triple dose gadolinium.
排除标准
- •Primary or secondary progressive multiple sclerosis, pregnancy, clinical relapse or systemic glucocorticoid therapy within 30 days prior to baseline scan, contraindications to closed magnet MRI scanning including claustrophobia, metal foreign body contraindications, allergy to gadolinium. Kurtzke expanded disability scale score greater than 5, past renal calculus, peanut allergy, defined biochemical abnormalities, intercurrent condition which could impair adherence to study protocol.
研究者
相似试验
进行中（未招募）
1 期
Trial of oxytocin for the treatment of emotional withdrawal symptoms and for relapse prevention in abstinent heroin dependent individualsOpioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individuals experience following detoxification.MedDRA version: 20.0 Level: LLT Classification code 10057379 Term: Addiction relapse System Organ Class: 100000004873MedDRA version: 20.0 Level: LLT Classification code 10001126 Term: Addiction any drug System Organ Class: 100000004873EUCTR2014-002708-26-GBniversity of Surrey3
招募中
3 期
Ivermectin to prevent CoronavirusCOVID-19SARS-CoV-2Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesPublic Health - EpidemiologyACTRN12621001535864Monash University1,000
尚未招募
3 期
Evaluating The desired effect Of the drug Imeglimin In Patients With Polycystic Ovarian SyndromeCTRI/2024/06/068921Riya Sharma self
已完成
不适用
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with obsessive-compulsive disorder (OCD)Mental and Behavioural DisordersObsessive-compulsive disorderISRCTN70977225Institute of Psychiatry, Kings College London (UK)24
进行中（未招募）
1 期
A randomised double-blind placebo-controlled pilot study of D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorderEUCTR2008-006947-38-GBKing's College London (Institute of Pyschiatry)24